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a gD Receptor but Not Necessarily Heparan Sulfate
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To characterize cellular factors required for herpes simplex virus type 1 (HSV-1)-induced cell fusion, we used an efficient
and quantitative assay relying on expression of HSV-1 glycoproteins in transfected cells. We showed the following: (1) Cell
fusion depended not only on expression of four viral glycoproteins (gB, gD, and gH-gL), as previously shown, but also on
expression of cell surface entry receptors specific for gD. (2) Cell fusion required expression of all four glycoproteins in the
same cell. (3) Heparan sulfate was not required for cell fusion. (4) Coexpression of receptor with the four glycoproteins in
the same cell reduced fusion activity, indicating that interaction of gD and receptor can limit polykaryocyte formation. Overall,
the viral and cellular determinants of HSV-1-induced cell fusion are similar to those for viral entry, except that HSV-1 entry
is significantly enhanced by binding of virus to cell surface heparan sulfate. © 2001 Academic Press
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Multinucleated giant cells are a hallmark of herpes
simplex virus type 1 (HSV-1) lesions in vivo (Spear,
1993a). In cultured cells, however, wild-type HSV-1
strains usually do not form polykaryocytes. Nonlethal
mutations in one of several HSV-1 genes, including gB
(UL27), gK (UL53), UL20, and UL24, can give rise to
polykaryocyte-forming mutants in vitro (Baines et al.,
1991; Bond and Person, 1984; Bzik et al., 1984; Cai et al.,
988; Debroy et al., 1985; DeLuca et al., 1982; Dolter et
al., 1994; Engel et al., 1993; Gage et al., 1993; Hutchinson
et al., 1992b; Jacobson et al., 1989; Pogue-Geile and
pear, 1987; Ruyechan et al., 1979; Sanders et al., 1982;
eise et al., 1987). In addition to a syncytial mutation,
SV-1-induced polykaryocyte formation requires the ex-
ression of several viral glycoproteins, including gB, gD
US6), gH (UL22), and gL (UL1), the latter two of which
re often designated as gH-gL because they are het-
rodimers (Hutchinson et al., 1992a). The evidence is
wofold. First, viral mutants that fail to express any one of
hese four glycoproteins will not form polykaryocytes
Cai et al., 1988; Davis-Poynter et al., 1994; Ligas and
ohnson, 1988; Roop et al., 1993). Second, expression of
SV-1 gB, gD, and gH-gL is necessary and sufficient to
nduce cell fusion in a Cos–Vero cell transfection system
Turner et al., 1998). Similarly, expression of HSV-2 gB,
1 To whom correspondence and reprint requests should be ad-
ressed at Northwestern University Medical School, Department of
icrobiology-Immunology, Mail Code S213, Room Ward 6-241, 320 Eastuperior Street, Chicago, IL 60611. Fax: (312) 503-1339. E-mail:
-spear@northwestern.edu.
313D, and gH-gL in various cell lines results in polykaryo-
yte formation (Muggeridge, 2000).
Additional viral proteins can influence the ability of
SV-1 to form polykaryocytes in cultured cells. For ex-
mple, studies with viral mutants deleted for specific
enes suggest that gE (US8), gI (US7), gM (UL10), and
L45 can enhance syncytium formation (Davis-Poynter
t al., 1994; Haanes et al., 1994; Visalli and Brandt, 1991),
whereas gC (UL44) can inhibit fusion of at least some
cell types (Manservigi et al., 1977; Novotny et al., 1996;
Pertel and Spear, 1996). This latter observation may par-
tially explain the absence of gC expression in many
syncytial mutants (Spear, 1993a). In all these above-cited
studies, it was not determined whether specific cell re-
ceptors for viral ligands were required for polykaryocyte
formation or whether the requirements for various viral
proteins in different cell types could be dependent on
which cell receptors were expressed, assuming recep-
tors are necessary.
HSV-1 entry is related to HSV-1-induced cell fusion, as
penetration proceeds by fusion of the viral envelope with
the cell membrane and requires many of the same viral
glycoproteins. Initial binding of HSV-1 occurs through an
interaction of gC (UL44) or gB with cell surface glycos-
aminoglycans (GAGs), primarily heparan sulfate (Herold
et al., 1991, 1994; Gruenheid et al., 1993; Shieh et al.,
1992; Vaheri and Cantell, 1963; WuDunn and Spear,
1989). Subsequent fusion between the virion envelope
and cell membrane requires gB, gD, and gH-gL, and
possibly the tegument protein UL25 (Addison et al., 1984;
Cai et al., 1988; Forrester et al., 1992; Ligas and Johnson,
1988; Roop et al., 1993). Penetration of virus requires the
0042-6822/01 $35.00
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314 PERTEL ET AL.interaction of gD with specific cell surface receptors
(Cocchi et al., 1998; Geraghty et al., 1998; Montgomery et
al., 1996; Warner et al., 1998) or heparan sulfate modified
by 3-O-sulfotransferases (3-OST) (Shukla et al., 1999a).
Proteins from two families can function as gD recep-
ors and mediate HSV-1 entry. Herpesvirus entry media-
or (HVEM), a member of the tumor necrosis factor (TNF)
eceptor family, can mediate entry of wild-type HSV-1 into
hinese hamster ovary (CHO) cells, a cell line normally
esistant to HSV-1 infection (Montgomery et al., 1996).
HVEM was also previously designated herpesvirus entry
protein A (HveA) (Warner et al., 1998) but will be called
HVEM here because most publications use this name.
Additional entry receptors are members of the immuno-
globulin superfamily, including proteins originally desig-
nated poliovirus receptor-related protein 1 (Prr1) or HveC
(Geraghty et al., 1998) and poliovirus receptor-related
protein 2 (Prr2) or HveB (Warner et al., 1998). HveC and
HveB were recently renamed nectin-1 and nectin-2, re-
spectively, on the basis of function in cells (Spear et al.,
2000). Nectin-1 and nectin-2 are cell adhesion molecules
that localize to cadherin-based cell junctions (Aoki et al.,
1997; Lopez et al., 1998; Satoh-Horikawa et al., 2000;
Takahashi et al., 1999).
As mentioned above, the viral ligand for HVEM, nec-
tin-1, and nectin-2 is gD (Cocchi et al., 1998; Geraghty et
al., 2000; Krummenacher et al., 1998; Nicola et al., 1998;
Whitbeck et al., 1997). Single amino acid substitutions in
gD (Rid mutations) can alter the ability of virus to interact
with a specific receptor. For example, nectin-2 mediates
entry of specific HSV-1 mutants that express Rid forms of
gD (gD-Rid) but cannot mediate entry of wild-type HSV-1
strains (Lopez et al., 2000; Warner et al., 1998). In con-
trast, HVEM mediates entry of wild-type virus but not Rid
mutants (Montgomery et al., 1996). Nectin-1 can mediate
entry of both wild-type HSV-1 strains and HSV-1 Rid
mutants (Geraghty et al., 1998; Menotti et al., 2000).
The cellular factors required for HSV-1-induced cell
fusion are less well defined. A requirement for heparan
sulfate was suggested by findings that the syncytial
mutant HSV-1(MP) could induce the fusion of wild-type
CHO cells but not of mutant cells defective for heparan
sulfate or all GAG biosynthesis (Shieh and Spear, 1994).
Wild-type CHO cells are more susceptible to HSV-1(MP)
entry than to most HSV-1 strains (Shieh et al., 1992; Shieh
and Spear, 1994), and it may be that HSV-1(MP) uses an
unidentified hamster cell surface receptor that is depen-
dent on synthesis of heparan sulfate. A different syncytial
mutant, HSV-1(KOS)804, fails to induce the fusion of wild-
type CHO cells (Terry-Allison et al., 1998). However, CHO
cells expressing HVEM, nectin-1, or nectin-2 can fuse
when transfected with HSV-1(KOS)804 genomic DNA,
depending on the form of gD expressed (Terry-Allison et
al., 1998, 2000). HSV-1(KOS)804, which expresses wild-
type gD, can fuse CHO cells expressing HVEM or nec-
tin-1 but not nectin-2. In contrast, HSV-1(KOS)804 recom-
e
sbinants expressing Rid1 gD can fuse CHO cells express-
ing nectin-1 or nectin-2 but not HVEM. In these studies it
was noted that inhibition of GAG sulfation could partially
inhibit cell fusion mediated by nectin-2 but not nectin-1
or HVEM. Because these studies were performed under
conditions by which all viral genes could be expressed,
it was unclear whether viral proteins in addition to gD
might influence receptor requirements for cell fusion.
Here we describe a quantitative and efficient cell fu-
sion assay based on the expression of a limited subset
of viral glycoproteins and defined entry receptors. We
demonstrate that cell fusion induced by HSV-1 glycopro-
teins required the expression of specific viral entry re-
ceptors but not heparan sulfate or chondroitin sulfate, at
least not as coreceptors with HVEM, nectin-1, or nectin-2.
In addition, all four viral glycoproteins (gB, gD, and gH-
gL) were necessary and sufficient for cell fusion, regard-
less of which entry receptor was available. Cell fusion
was observed only when all four viral glycoproteins were
expressed in the same cell and when the form of gD
expressed (wild-type or Rid) was compatible with the
available receptor. Coexpression of an entry receptor
with the four glycoproteins in the same cell reduced the
efficiency of cell fusion. These results define a minimal
set of requirements for HSV-induced cell fusion, with
respect to viral glycoproteins and cell surface receptors,
and indicate that an interference phenomenon in opera-
tive in cell fusion.
RESULTS
Cell fusion requires an entry receptor and four HSV-1
glycoproteins
Genes encoding the four HSV-1 glycoproteins, gB, gD,
gH, and gL, were cloned into the plasmid pCAGGS/MCS,
which permits expression of inserts under control of the
chicken b-actin promoter and human cytomegalovirus
(CMV) immediate-early (IE) enhancer (Niwa et al., 1991).
s shown in Fig. 1, transfection of the resulting four
lasmids into cells susceptible to HSV-1 infection (Vero,
eLa, and PEAK cells) resulted in the formation of
olykaryocytes. The polykaryocytes were larger and
ore numerous on PEAK cells than on the other cell
ypes, perhaps reflecting relative efficiencies of transfec-
ion. CHO-K1 cells, which lack an entry receptor for
ild-type HSV-1 and are not susceptible to infection,
ailed to form polykaryocytes (Fig. 1). This is despite the
resence of all four glycoproteins on the cell surface, as
hown in Fig. 2, regardless of whether each glycoprotein
as expressed alone or in combination. Less cell sur-
ace expression of gB, gD, or gD-Rid was noted when all
our glycoproteins were expressed together rather than
lone. This may represent differences in expression,
xposure on the cell surface, or ability to detect expo-
ure. However, as shown below, CHO-K1 cells express-
( the in
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315CELL FUSION INDUCED BY HSV GLYCOPROTEINS AND RECEPTORSing all four glycoproteins could induce polykaryocytes if
mixed with cells expressing HSV-1 entry receptors.
These results confirm previous studies indicating that
all four HSV-1 or HSV-2 glycoproteins (gB, gD, and gH-gL)
are necessary to induce the fusion of transfected cells
(Muggeridge, 2000; Turner et al., 1998). Figure 1 shows
that expression of these four glycoproteins alone is not
sufficient because CHO-K1 cells did not fuse. We thus
tested whether CHO-K1 cells expressing one of the
known entry receptors could be induced to fuse by the
four HSV-1 glycoproteins. Because HSV-1 entry mediated
by HVEM, nectin-1, or nectin-2 depends on expression of
an appropriate form of gD by virus, we also tested
whether the ability of receptor-bearing cells to fuse de-
pends on the form of gD expressed. To these ends, we
mixed CHO-K1 cells expressing HSV-1 glycoproteins
with CHO-K1 cells expressing herpesvirus entry recep-
tors. In these and subsequent experiments, we defined
effector cells as the cells expressing the HSV-1 glyco-
proteins and target cells as the cells to which we added
the effector cells.
As shown in Fig. 3, effector cells expressing gB, gD,
and gH-gL could form polykaryocytes with target cells
expressing HVEM or nectin-1 (CHO-HVEM or CHO-nec-
tin-1). We observed no polykaryocytes when we mixed
effector cells with CHO-nectin-2 cells. In contrast, effec-
tor cells expressing gB, gD-Rid, and gH-gL could form
polykaryocytes with CHO-nectin-1 and CHO-nectin-2
cells but not with CHO-HVEM cells. As expected, the
effector cells failed to induce fusion with CHO-K1 cells
expressing no receptor.
To quantify HSV-1 glycoprotein-mediated cell fusion,
we used a luciferase reporter gene activation assay
(Okuma et al., 1999). We expressed T7 RNA polymerase
FIG. 1. HSV-1 glycoprotein-induced fusion of cell lines susceptible t
CHO-K1) to HSV-1 infection were transfected with plasmids expressing
nd then stained with Giemsa. Shown are photographs of representatand the HSV-1 glycoproteins of interest in effector cells
and examined the activation of a luciferase reporter geneunder control of the T7 promoter in target cells after
cocultivating the two cell populations. As shown in Table
1, a significant enhancement in luciferase activity was
detected only under the experimental conditions that
resulted in polykaryocyte formation, as shown in Fig. 3.
In addition, expression of fewer than all four HSV-1 gly-
coproteins in the effector cells resulted in no significant
luciferase activity (Table 1) and no polykaryocyte forma-
tion (data not shown). This finding was true for all three
target cell lines tested, CHO-HVEM, CHO-nectin-2, and
CHO-nectin-1.
Thus, the induction of cell fusion requires, at a mini-
mum, expression of four viral glycoproteins (gB, gD, and
gH-gL) and a herpesvirus entry receptor, such as the
gD-receptors HVEM, nectin-1, or nectin-2.
Kinetics of HSV-1 glycoprotein-mediated cell fusion
To study the kinetics of fusion, we followed expres-
sion of luciferase activity and polykaryocyte formation
over time. As shown in Fig. 4, maximal luciferase
activity occurred approximately 18 h after cocultivating
effector and susceptible target cells. Polykaryocytes
were first visualized approximately 12 h after coculti-
vating effector and target cells, but were most promi-
nent between 24 and 36 h (Fig. 5). Figure 5 shows
results obtained using CHO-nectin-1 target cells but
similar results were seen with the other susceptible
target cells (data not shown). In general, the number
and size of visible polykaryocytes correlated with the
level of luciferase activity until 18 h.
In the time-course experiments, luciferase activity
consistently decreased after 18 h, while the number of
polykaryocytes remained the same or even increased.
infection. Cell lines susceptible (Vero, HeLa, and PEAK) and resistant
dicated HSV-1 glycoproteins. After incubation for 24 h, cells were fixed
l monolayers.o viralThe decline in luciferase activity most likely resulted
from loss of functional plasmids along with rapid deg-
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316 PERTEL ET AL.radation of luciferase mRNA and protein (Thompson et
al., 1991). Viral glycoproteins do not turn over rapidly
and, despite the loss of the plasmids, would be avail-
able to mediate further cell fusion.
In all the experiments presented here, the effector and
target cells were mixed and cocultivated 12 h after initi-
ating DNA transfection. We obtained similar time
courses when the cells were mixed and cocultivated 24 h
after initiating transfection. In both cases, maximal lucif-
erase activity was noted 18 h after cocultivating the
effector and target cells. However, the level of luciferase
FIG. 2. Cell surface expression of HSV-1 glycoproteins detected by
inding of specific antibodies. CHO-K1 cells were transfected with
lasmids expressing the indicated HSV-1 glycoproteins. After replating
nto 96-well dishes and overnight incubation, cells were incubated
ith primary antibody diluted in PBS with 3% BSA. Cells were subse-
uently fixed and then sequentially incubated with species-specific
iotinylated anti-IgG conjugate and streptavidin-b-galactosidase con-
ugate. After addition of ONPG substrate, OD readings were obtained.
hown are the mean values and standard deviations for five replicate
amples.expression was lower for cells mixed at 24 h after trans-
fection (data not shown).Cell surface glycosaminoglycans are not required for
cell fusion
It was shown previously that undersulfation of cell
surface GAGs partially reduces the level of HSV-1-in-
duced fusion of cells expressing nectin-2 but not nectin-1
or HVEM (Terry-Allison et al., 2000). In this study, how-
ever, viral genomes were transfected into cells to induce
cell fusion, permitting expression of all viral proteins,
some of which might have influenced the results. More-
over, fusion was assessed by microscopic analysis and
was difficult to quantitate. To investigate whether cell
surface GAGs are required for glycoprotein-induced cell
fusion, we used the luciferase assay to quantitate the
amount of fusion induced by HSV-1 glycoproteins in
GAG-deficient cells compared with that of wild-type cells.
We used CHO-K1 cells and the xylosyltransferase-defi-
cient cell line CHO-745, which does not produce either
heparan or chondroitin sulfate (Esko et al., 1985).
CHO-K1 and CHO-745 cells were transfected with plas-
mids expressing the desired receptors along with the
luciferase reporter plasmid to serve as target cells. The
same two cell lines were transfected with all four glyco-
proteins and T7 RNA polymerase to serve as effector
cells. CHO-K1 effectors were mixed with CHO-K1 targets
and CHO-745 effectors were mixed with CHO-745 tar-
gets, respectively, and the induction of luciferase activity
was quantitated.
As shown in Fig. 6, cocultivation of mutant effector and
target cells deficient for both heparan sulfate and chon-
droitin sulfate, or of wild-type cells, resulted in induction
of luciferase activity, provided the target cells expressed
an appropriate gD-specific entry receptor. Consistent
with our previous results, expression of wild-type gD was
required for efficient fusion with target cells that ex-
pressed HVEM or nectin-1, whereas gD-Rid was required
for target cells that expressed nectin-2 or nectin-1, re-
gardless of whether the cells were wild-type or GAG-
negative. Microscopic analysis of the cell mixtures in
which luciferase activity was significantly enhanced re-
vealed the presence of polykaryocytes in both the wild-
type and GAG-negative cells (data not shown). Similar
results were obtained from three additional experiments
(data not shown). In all these experiments, luciferase
activities observed with the GAG-negative cells were
either comparable to, or slightly lower than, those ob-
served with the wild-type CHO cells. Because, in the two
different cell types, it is difficult to control for the number
of transfected cells, the levels of transiently expressed
proteins and replating efficiencies, we cannot exclude
the possibility that GAGs may influence the level of cell
fusion. We can conclude, however, that expression of
heparan sulfate or chondroitin sulfate is not required for
HSV-1 glycoprotein-induced cell fusion dependent on
HVEM, nectin-1, or nectin-2.
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317CELL FUSION INDUCED BY HSV GLYCOPROTEINS AND RECEPTORSEfficient fusion requires that HSV-1 gB, gD, and gH-gL
are expressed in the same cell
To determine whether cell fusion requires expression
of gB, gD, and gH-gL in the same cell, we transfected
CHO-K1 and CHO-nectin-1 cells with different combina-
tions of HSV-1 glycoproteins and then cocultivated the
cells. Two findings are evident from the results of these
experiments (Table 2): (1) Polykaryocytes were visualized
only when all four glycoproteins were transfected to-
gether into the same cell, either CHO-K1 or CHO-nectin-1
FIG. 3. HSV-1 glycoprotein-induced cell fusion depends on both the e
ith plasmids expressing the indicated HSV-1 glycoproteins or with c
HO-nectin-1 target cells. After incubation for 24 h, the cells were fixed
onolayers.
T
Viral Glycoproteins and Receptors Required
Glycoproteins expressed in
CHO-K1 effector cells CHO-K1
Vector 5.8 6 1.2
gB, gD 1.3 6 0.2
gB, gD-Rid 3.3 6 1.1
gB, gH, gL 3.1 6 1.2
gD, gH, gL 0.8 6 0.1
gD-Rid, gH, gL 1.9 6 0.1
gB, gD, gH, gL 1.2 6 0.2
gB, gD-Rid, gH, gL 4.5 6 1.5
Note. CHO-K1 effector cells were transfected with plasmids expre
CHO-HVEM, CHO-nectin-2, and CHO-nectin-1 target cells were transf
hours after cocultivating the effector and target cells. Shown are the mean RL
triplicate. An additional experiment yielded similar results (data not shown).cells. In both cases, there were receptor-bearing cells
with which glycoprotein-expressing cells could fuse. (2)
Significant luciferase activity was detected only when all
four glycoproteins were transfected into the CHO-K1
cells and then mixed with receptor-bearing cells. In this
situation, the CHO-K1 cells expressing the glycoproteins
and T7 RNA polymerase could fuse with receptor-bear-
ing CHO-nectin-1 cells and induce luciferase activity.
However, when CHO-nectin-1 cells were transfected
with the glycoproteins, these cells could fuse only with
eptor and the form of gD expressed. CHO-K1 effector cells transfected
vector were cocultivated with CHO-K1, CHO-HVEM, CHO-nectin-2, or
en stained with Giemsa. Shown are photographs of representative cell
ll Fusion Quantitated by Luciferase Activity
rase activity (RLU) induced in target cells
HVEM CHO-nectin-2 CHO-nectin-1
6 0.3 3.7 6 0.9 4.1 6 0.4
6 0.1 1.3 6 1.1 1.7 6 0.3
6 0.4 1.4 6 0.4 1.3 6 0.2
6 0.5 3.4 6 0.7 3.6 6 1.5
6 0.3 1.6 6 0.6 3.5 6 1.4
6 0.3 2.0 6 1.1 2.9 6 0.5
6 8.2 0.6 6 0.3 130 6 43
6 0.9 140 6 82 1100 6 90
he indicated HSV-1 glycoproteins and T7 RNA polymerase. CHO-K1,
ith luciferase reporter plasmid. Luciferase activity was measured 18ntry rec
ontrolABLE 1
for Ce
Lucife
CHO-
2.2
0.8
1.1
2.8
1.0
1.0
29
2.7
ssing t
ected wU values and standard deviations from one experiment performed in
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318 PERTEL ET AL.other receptor-bearing cells but not with CHO-K1 cells
expressing T7 RNA polymerase. Cells that did not ex-
press either glycoproteins or receptor were not incorpo-
rated into polykaryocytes as innocent bystanders.
Fusion can be inhibited by expressing receptor and
HSV-1 glycoproteins in the same cell
Although we noted efficient polykaryocyte formation
when receptor-bearing cells were transfected with all
four HSV-1 glycoproteins, many cells did not fuse and the
maximal size of the polykaryocytes was limited. Also,
when glycoprotein-expressing effector cells fuse with
receptor-bearing target cells, both viral glycoproteins
and receptor are now coexpressed in the resulting
polykaryocyte. Given that coexpression of gD with nec-
tin-1 was previously shown to result in physical interac-
tions between the two that correlate with loss of receptor
availability for viral entry (Geraghty et al., 2000), coex-
ression of gD and receptor within the same cell or
FIG. 4. Kinetics of cell fusion as measured by luciferase production.
Luciferase activity was measured at the indicated times after coculti-
vating effector and target cells. CHO-K1 effector cells were transfected
with plasmids expressing the indicated HSV-1 glycoproteins or control
vector and T7 RNA polymerase. CHO-HVEM, CHO-nectin-2, and CHO-
nectin-1 target cells were transfected with luciferase reporter plasmid.
Two separate experiments each in duplicate were performed. Shown
are mean relative luminosity unit (RLU) values and corresponding
ranges.olykaryocyte could result in loss of gD availability for
nitiation or enlargement of polykaryocytes.To test this possibility, we transfected effector cells
ith the four required HSV-1 glycoproteins along with
ifferent entry receptors before cocultivating the cells
ith receptor-bearing target cells. In these experiments,
e used combinations of glycoproteins and entry recep-
ors that we previously showed could mediate cell fu-
ion. Thus, CHO-K1 cells were transfected with plasmids
xpressing HSV-1 gB, gD, and gH-gL, and also with a
lasmid expressing HVEM or nectin-1 or empty vector,
nd were then cocultivated with CHO-HVEM or CHO-
ectin-1 target cells, respectively. Similarly, CHO-K1 cells
ere transfected with plasmids expressing gB, Rid-gD,
nd gH-gL, and also with a plasmid expressing nectin-2
r nectin-1 or empty vector, and then cocultivated with
HO-nectin-2 or CHO-nectin-1 target cells, respectively.
s shown in Fig. 7, coexpression of HVEM or nectin-1
ith gB, gD, and gH-gL reduced the induction of lucif-
rase activity after cocultivation with the appropriate
arget cells to approximately 42 and 9% of the control
evels, respectively (Fig. 7, left panel). Coexpression of
ectin-2 and nectin-1 with gB, Rid-gD, and gH-gL re-
uced luciferase activity to approximately 13 and 2% of
he control values, respectively (Fig. 7, right panel). Thus,
ells expressing both receptor and HSV-1 glycoproteins
use less efficiently with susceptible cells. This most
ikely results from interactions between gD and receptor
n the effector cells that block gD binding to receptor on
arget cells.
DISCUSSION
We utilized a quantitative and efficient cell fusion as-
ay to identify viral and cell surface requirements for cell
usion induced by HSV-1. We showed that four viral gly-
oproteins (gB, gD, and gH-gL) are necessary for cell
usion, confirming results obtained by others for HSV-1 or
SV-2 glycoproteins expressed in various primate cell
ypes (Muggeridge, 2000; Turner et al., 1998). In these
previous studies, the potential requirement for cell sur-
face receptors was not directly addressed, although sol-
uble gD that can bind HSV entry receptors was shown to
block HSV-2-induced cell fusion (Muggeridge, 2000).
Here we show that expression of the four HSV-1 glyco-
proteins is not sufficient but that cell fusion also requires
the expression of an HSV-1 entry receptor in the target
cells. It was reported that an anti-nectin-1 antibody ca-
pable of blocking viral entry failed to block cell fusion
induced by two syncytial strains of HSV-1 (Cocchi et al.,
2000). This result is not necessarily inconsistent with our
conclusion that an entry receptor is required for cell
fusion because entry receptors participating in cell fu-
sion may not have been accessible to the antibody used
or entry receptors other than nectin-1 may have been
used. One of the strains used in this study, HSV-1(MP),
was previously shown to infect cells devoid of all the
known entry receptors (Montgomery et al., 1996).
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319CELL FUSION INDUCED BY HSV GLYCOPROTEINS AND RECEPTORSThe entry receptors demonstrated here to provide re-
ceptors for cell fusion were HVEM, nectin-1, and nectin-2.
Each of these cell surface receptors binds to either
wild-type gD or gD-Rid and mediates fusion in accor-
dance with the form of gD expressed and recognized.
Cell surface heparan sulfate or other GAGs were not
required as coreceptors for cell fusion when the entry
receptors expressed were HVEM, nectin-1, or nectin-2.
Thus, the viral and cellular determinants of HSV-1-
induced cell fusion are similar to those required for viral
entry (Spear et al., 2000), except that entry is significantly
enhanced by the presence of cell surface heparan sul-
fate, whereas cell fusion did not require expression of
heparan sulfate or chondroitin sulfate. A likely explana-
tion for this apparent difference in requirements is as
follows. Although binding of virus to cells may be largely
dependent on the binding of virus to heparan sulfate and
subsequent virus-cell fusion depends on prior binding of
virus, cocultivated cells can have close contacts medi-
ated by cell factors other than heparan sulfate.
Results presented elsewhere also highlight the re-
quirement for HSV-1 entry receptors in HSV-1-induced
cell fusion and demonstrate relatively little effect on cell
fusion of altering GAG structure by use of sulfate inhib-
itors (Terry-Allison et al., 1998, 2000). However, these
esults were obtained by use of transfected viral ge-
omes rather than plasmids expressing individual viral
lycoproteins, so that effects of other viral gene products
FIG. 5. Kinetics of cell fusion as assessed microscopically. At the ind
and stained with Giemsa. Shown are photographs of representative ce
cells.n the results could not be ruled out. For example,
eletion of the gene for gE, gI, gM, or UL45 was previ-ously reported to abrogate cell fusion induced by syncy-
tial strains of HSV-1 (Davis-Poynter et al., 1994; Haanes
et al., 1994; Visalli and Brandt, 1991), while expression of
gC may inhibit the fusion of at least some cell types
(Manservigi et al., 1977; Novotny et al., 1996; Pertel and
pear, 1996). The cell fusion assay described here
hould be very useful for assessing the ability of these
ther viral proteins to influence fusion induced by the
ssential glycoproteins interacting with defined cell sur-
ace receptors.
Although we found, using HSV-1(KOS) glycoproteins,
hat GAGs were not necessary for cell fusion dependent
n HVEM, nectin-1, or nectin-2, this finding may not be
eneralizable to other HSV strains or to other entry re-
eptors. Polykaryocyte formation by the syncytial strain
SV-1(MP) was shown to depend on the expression of
AGs in CHO cells (Shieh and Spear, 1994). Possibly
SV-1(MP) can use as an entry and fusion receptor an
nidentified hamster cell surface molecule that is depen-
ent on expression of heparan sulfate. It should be noted
hat a nonprotein entry receptor was identified for HSV-1,
amely sites in heparan sulfate generated by the action
f specific 3-O-sulfotransferases (Shukla et al., 1999a). It
seems reasonable to predict that HSV-1 glycoproteins
could induce the fusion of cells expressing this modified
form of heparan sulfate as the only entry receptor, and
that this cell fusion would be totally dependent on the
expression of heparan sulfate and the appropriate 3-O-
times, duplicate plates from the experiment shown in Fig. 4 were fixed
layers from the cocultivation of effector cells and CHO-nectin-1 targeticatedsulfotransferase. Although this enzyme is not normally
expressed in CHO cells, it may be that HSV-1(MP) can
sults were obtained in three additional experiments (data not
shown).
t
18 hours after cocultivating CHO-K1 and CHO-nectin-1 cells. Shown are mean
in triplicate. Two additional experiments yielded similar results (data not sho
320 PERTEL ET AL.utilize heparan sulfate with the normal CHO pattern of
sulfation as an entry and cell fusion receptor.
Recent results obtained with pseudorabies virus
(PRV), a related alphaherpesvirus, indicate that the PRV
roteins Are Expressed in the Same Cell
Luciferase
activity (RLU)
Visible
polykaryocytes
220 6 14 Yes
0.5 6 0.3 No
0.6 6 0.2 No
1.2 6 0.1 No
0.2 6 0.0 No
0.7 6 0.2 No
0.8 6 0.1 No
5.0 6 0.8 Yes
xpressing the indicated HSV-1 glycoproteins. CHO-K1 cells were also
ed with luciferase reporter plasmid. Luciferase activity was measured
FIG. 7. Entry receptors coexpressed with HSV-1 glycoproteins in the
effector cells inhibit cell fusion. In addition to all four HSV-1 glycopro-
teins and T7 RNA polymerase, CHO-K1 effector cells were transfected
with either vector alone or plasmid expressing the entry receptor of
interest. CHO-HVEM, CHO-nectin-1, and CHO-nectin-2 target cells were
transfected with luciferase reporter plasmid. Luciferase activity was
measured 18 h after cocultivating the effector and target cells. Results
are presented as the luciferase activity obtained with effector cells
coexpressing receptor as a percentage of the activity obtained with
effector cells not expressing receptor. The panel on the left shows
results for effector cells transfected with gB, gD, and gH-gL and
cocultivated with CHO-HVEM or CHO-nectin-1 target cells. The panel
on the right shows results for effector cells transfected with gB, Rid-gD,
and gH-gL and cocultivated with CHO-nectin-2 and CHO-nectin-1 tar-
get cells. In all cases, the receptor transfected into the effector cells
was the same as the receptor expressed in the target cells. Shown are
the mean values and 95% confidence intervals from one experiment
performed in triplicate. Similar results were obtained in one additional
experiment (data not shown).FIG. 6. Cell surface expression of heparan sulfate and chondroitin
sulfate are not required for cell fusion. Effector cells were trans-
fected with plasmids expressing HSV-1 gB, gD, and gH-gL or with
control vector and T7 RNA polymerase. Target cells were trans-
fected with luciferase reporter plasmid and plasmids expressing
HVEM, nectin-2, or nectin-1. Both the effector and target cells were
CHO-K1 cells in the left panel and CHO-745 cells in the right panel.
Luciferase activity was measured 18 h after cocultivating the effec-
tor and target cells. Shown are the mean values and standard
deviations from one experiment performed in triplicate. Similar re-TABLE 2
Cell Fusion Requires That All Four HSV-1 Glycop
Glycoprotein expressed
CHO-K1 cells
(T7 RNA polymerase)
CHO-nectin-1 cells
(luciferase reporter plasmid)
gB, gD, gH, gL Vector
gB, gD gH, gL
gD, gH, gL gB
gD gB, gH, gL
gB gD, gH, gL
gB, gH, gL gD
gH, gL gB, gD
Vector gB, gD, gH, gL
Note. CHO-K1 cells and CHO-nectin-1 cells were transfected with vectors e
ransfected with T7 RNA polymerase, while CHO-nectin-1 cells were transfectRLU values and standard deviations from one experiment performed
wn).
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321CELL FUSION INDUCED BY HSV GLYCOPROTEINS AND RECEPTORSrequirements for cell fusion differ from those for HSV. It
was shown that transfection of plasmids expressing PRV
gB and gH-gL was sufficient to induce the fusion of rabbit
kidney cells (Klupp et al., 2000). This finding is in keeping
ith previous studies showing that, in contrast to HSV-1,
RV can form plaques in the absence of PRV gD (Peeters
t al., 1992; Rauh and Mettenleiter, 1991). However, PRV
nd HSV-1 are alike in that (1) gB, gD, and gH-gL are all
equired for virion infectivity and viral penetration (Met-
enleiter, 2000; Spear, 1993b) and (2) nectin-1 and nec-
in-2 bind to both HSV-1 and PRV gD (Geraghty et al.,
000; Krummenacher et al., 1998) and can serve as entry
eceptors for both viruses (Geraghty et al., 1998; Shukla
t al., 1999b, 2000; Warner et al., 1998). Interestingly,
D-negative mutants of PRV are noninfectious but can
cquire secondary mutations during forced passage that
ermit the production of weakly infectious virus in the
bsence of gD (Schmidt et al., 1997). Taken together,
hese findings suggest that, even for HSV, gD may not be
n essential component of the viral membrane-fusing
achinery but, through binding to a receptor, may serve
s the usual trigger for activating membrane fusion. In
he case of PRV, and perhaps also HSV, there may be
dditional receptors capable of interacting with gB or
H-gL to induce membrane fusion. The cell fusion assay
escribed here should facilitate further definition of the
ariables that can influence alphaherpesvirus-induced
ell fusion.
MATERIALS AND METHODS
ells
J. D. Esko (University of California, San Diego) pro-
ided wild-type CHO-K1 cells and a mutant CHO cell line,
gsA-745 (designated here as CHO-745). CHO-745 cells
re xylosyltransferase-deficient and do not produce ei-
her heparan sulfate or chondroitin sulfate (Esko et al.,
985). HVEM (CHO-HveA35), nectin-2 (CHO-Prr2), and
ectin-1 (CHO-Prr1) expressing CHO cells were previ-
usly described (Geraghty et al., 1998; Montgomery et
l., 1996; Warner et al., 1998) and are designated here as
HO-HVEM, CHO-nectin-2, and CHO-nectin-1, respec-
ively. All CHO cell lines were passaged in Ham’s F12
edium (Gibco BRL, Gaithersburg, MD) supplemented
ith 10% fetal bovine serum (FBS) and Geneticin (400
mg/ml; Gibco BRL). Vero cells are an adult African green
monkey cell line obtained from American Tissue Culture
Collection (ATCC, Rockville, MD), and were passaged in
199 medium supplemented with 5% FBS. HeLa cells are
derived from a cervical epitheloid carcinoma (ATCC).
PEAK cells are human embryonic kidney cells that ex-
press the large T antigen and are modified to enhance
transfection efficiency (Edge BioSystems, Gaithersburg,
MD). HeLa and PEAK cells were passaged in Dulbecco’s
modified Eagle’s medium supplemented with 10% FBS.
f
SCell enzyme-linked immunosorbent assay (CELISA)
Subconfluent CHO-K1 cells were transfected with
plasmids expressing HSV-1 glycoproteins using lipo-
fectamine reagent (Gibco BRL). Individual wells were
transfected with 0.4 mg of each expression vector (0.8 mg
in the case of gB), keeping the total amount of DNA
added at 2.4 mg per well by the addition of empty vector
DNA. After incubation at 37°C in 5% CO2 for 8 h, the
transfection mixture was removed and Ham’s F12 con-
taining 10% FBS was added. The cells were incubated for
an additional 4 h before detaching with 0.25% trypsin and
1 mM tetrasodium ethylenediaminetetraacetic acid
(EDTA; Gibco BRL) and replating onto 96-well plates.
After incubation for 18 h, cells were washed with phos-
phate-buffered saline (PBS) and then incubated with pri-
mary antibody diluted in PBS containing 3% bovine se-
rum albumin (BSA). Mouse monoclonal antibodies used
included the anti-gH antibodies 52S and 53S (culture
supernatant diluted 1:1), the anti-gL antibodies VIII87 and
VIII200 (ascites fluid diluted 1:1000), and the anti-nectin-1
antibody XIV207 (undiluted culture supernatant). Rabbit
polyclonal antibodies used included the anti-gB antibody
R74, the anti-gD antibody R7, the anti-HVEM antibody
R11874, and the anti-nectin-2 antibody R146. All rabbit
antibodies were diluted 1:1000. Hybridoma cells produc-
ing 52S and 53S (HB8181 and HB8182, respectively) are
from ATCC. All other antibodies were previously de-
scribed (Herold et al., 1994; Isola et al., 1989; Montgom-
ery et al., 1996; Novotny et al., 1996; Warner et al., 1998),
xcept XIV207 (R. J. Geraghty and P. G. Spear, unpub-
ished data). Subsequently, cells were fixed with PBS
ontaining 2% formaldehyde and 0.2% gluteraldehyde
nd incubated sequentially with species-specific biotin-
lated anti-IgG conjugate and streptavidin-b-galactosi-
dase conjugate. After adding o-nitrophenol-b-D-glucopy-
anoside (ONPG) substrate (3 mg/ml in PBS; Sigma, St.
ouis, MO), optical density (OD) readings at 410 nm were
btained by a plate spectrophotometer (SpectraMax 250,
olecular Devices, Sunnyvale, CA).
onstruction of expression vectors
Y. Kawaoka (University of Wisconsin, Madison) pro-
ided the expression plasmid pCAGGS/MCS. This plas-
id was constructed by inserting a polylinker into
CAGGS (Kobasa et al., 1997). Proteins inserted into
CAGGS are expressed under control of the chicken
b-actin promoter and CMV IE enhancer (Niwa et al.,
1991).
The HSV-1(KOS) glycoprotein open reading frames of
interest were inserted into pCAGGS/MCS as follows. The
BamHI G fragment of genomic HSV-1(KOS) DNA, which
encodes the gB open reading frame, was digested with
KpnI, inserted into the KpnI site of pUC18, and screened
or orientation, generating pDW20 (D. WuDunn and P. G.
pear, unpublished data). PCR mutagenesis was used to
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322 PERTEL ET AL.generate an upstream BglII site and downstream MunI
site. For the BglII site, the two primer pairs consisted of
sense primer 59-GGCCCCCGTAGATCTGCCATGCAC-
CAGG-39 and antisense primer 59-TGGTACGCGATCA-
GAAAGCC-39 along with sense primer 59-CCCTCTTT-
GATCACTCCACC-39 and antisense primer 59-TGCATG-
CAGATCTACGGGGGCCCGTCG-39. For the MunI site,
he two primer pairs consisted of sense primer 59-
GACTTTGACGAGGCCAAGC-39 and antisense primer
9-GGTTTCAATTGACAACAAACCC-39 along with sense
rimer 59-GTTGTCAATTGAAACCACGG-39 and antisense
rimer 59-CCCAGTCACGACGTTGTAAA-39. The intro-
uced restriction endonuclease recognition sequences
re shown in bold. The Northwestern University Biotech-
ology Facility, the Great Lakes Regional Center for AIDS
esearch (CFAR), or Operon Technologies (Alameda,
A) constructed all primers used for cloning and se-
uencing. After removing an XbaI site in a noncoding
egion of the vector, the BglII and MunI sites were con-
erted into AvrII and XbaI sites, respectively, using link-
rs (AvrII linker: 59-GCCTAGGC-39; XbaI linker: 59-
CTCTAGAGC-39; New England Biolabs, Beverly, MA).
ubsequently, the gB gene was excised with AvrII and
baI, inserted into the NheI site of pCAGGS/MCS, and
screened for orientation, generating pPEP98. Nucleotide
sequencing (The Northwestern University Biotechnology
Facility and CFAR) of the gB open reading frame revealed
several polymorphisms previously described in other
HSV-1 strains, including KOS. One additional polymor-
phism was noted at nucleotide position 1544 (G to A) that
results in an arginine-to-histidine substitution. This poly-
morphism was in a region of the open reading frame
outside the region that could have been altered by PCR
mutagenesis. The gB nucleotide sequence was depos-
ited with GenBank (accession number AF311740).
Construction of plasmids containing HSV-1(KOS) gD
(pPEP26), HSV-1(KOS)Rid1 gD (pCJ1), and HSV-1(KOS)
gH (pMN7) and gL (pMN49) were previously described
(Geraghty et al., 2000; Novotny, 1996; Novotny et al., 1996;
Pertel and Spear, 1997). These glycoproteins were sub-
cloned into pCAGGS/MCS as follows. The gD gene was
excised by digestion with EcoRI and SphI and inserted
etween these sites of pCAGGS/MCS, generating
PEP99. The Rid1 gD gene was excised by sequential
igestion with AflII, large (Klenow) fragment of DNA poly-
erase I, and BamHI, and subsequently inserted be-
ween the SmaI and BglII sites of pCAGGS/MCS, gener-
ting pPEP108. The gH gene was excised with SacI and
phI and also inserted between these sites, generating
PEP100. The gL gene was excised by digestion with
coRI and NaeI and inserted between the EcoRI and
maI sites of pCAGGS/MCS, generating pPEP101.
The plasmid pCAGT7 expresses T7 RNA polymerase
sing the chicken b-actin promoter and CMV IE en-hancer (Okuma et al., 1999). The plasmid pT7EMCLuc
expresses the firefly luciferase gene using the T7 pro-moter. Y. Matsuura (National Institute of Infectious Dis-
eases, Tokyo, Japan) provided both plasmids. The plas-
mids expressing HVEM, nectin-2, and nectin-1 were de-
scribed previously (Geraghty et al., 1998; Montgomery et
al., 1996; Warner et al., 1998).
Fusion assays
Cell fusion was visualized by microscopy following
Giemsa staining or quantified using a luciferase reporter
gene activation assay. Photographs of the cells were
taken with an Olympus or Nikon digital camera. For the
luciferase assay (Okuma et al., 1999), subconfluent ef-
ector cells in six-well plates were transfected with the
ectors expressing the glycoproteins of interest and T7
NA polymerase. Target cells in six-well plates were
ransfected with a vector expressing luciferase under
ontrol of the T7 promoter. Individual wells were trans-
ected with 0.4 mg of each plasmid. The total amount of
DNA transfected per well was kept constant at 2.4 mg per
well by adding vector DNA. Lipofectamine reagent in
Opti-MEM was used for all transfections. After incuba-
tion at 37°C in 5% CO2 for 8 h, the transfection mixture
was removed, Ham’s F12 containing 10% FBS was
added, and the cells were incubated for an additional
4 h. The approximate cell density at this point was 2 3
104/well. Cells were subsequently detached using tryp-
sin-EDTA and washed with complete media. Effector and
target cells were mixed in a 1:1 ratio and then replated
onto 24-well dishes. Optimal luciferase expression oc-
curred when effector and target cells were detached,
mixed at a 1:1 ratio, and cocultivated 12 h after initiating
the transfection (data not shown). Six to 36 h later, lucif-
erase activity was quantified using the Luciferase Re-
porter Assay System (Promega, Madison, WI). Briefly,
after washing with PBS, cells were lysed with passive
lysis buffer, the supernatant was collected, and beetle
luciferin substrate was added. Luminosity readings were
obtained using a TD-20/20 luminometer (Turner Designs,
Promega, Madison, WI). Supernatants were diluted 1:10
for all readings.
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